The Mires of Research Evaluation

All organizations who fund and conduct scientific research are increasingly "under the gun" to better evaluate the performance of their programs. Scientific research is supported by two major sponsors; the federal government funds most basic research and industry supports the more applied research. These sponsors have organizational goals and obligations to their stakeholders. They must account for their expenditures and must justify these investment decisions. How to do so in a viable yet accep

Written byEliezer Geisler
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The key issue in research evaluation is the combination of the scientific process being such a complex phenomenon, and our constant desire to quantify its outcomes. This has led to the use of multiple indicators, such as counts of publications, counts of citations, and peer-review. The vast majority of the problems discussed by Phelan, Perry, and other writers are primarily due to the issues inherent in measuring complex phenomena with an array of indicators. Products from research include a wide variety of outcomes, from "nuggets" of knowledge to an array of ideas, concepts, methods, techniques, and explanations. Downstream outcomes include patents, prototypes, and design criteria. Certain metrics (such as bibliometrics) can only capture a portion of these outcomes. Moreover, these outcomes (or products) are differentially prioritized by performers and sponsors and create inherent conflicts.

Given that only a fraction of research is documented and captured by bibliometric measures, some, if ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH